Peripheral Neuropathy in Virologically Suppressed People Living with HIV: Evidence from the PIVOT Trial

The aim of this study is to identify the factors associated with peripheral neuropathy and to explore neurofilament light chain (NfL) as a biomarker for peripheral neuropathy (PN) in effectively virologically suppressed adults living with HIV. All protease inhibitor monotherapy versus ongoing triple...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Viruses Ročník 16; číslo 1; s. 2
Hlavní autori:	Schuldt, Anna L., Bern, Henry, Hart, Melanie, Gompels, Mark, Winston, Alan, Clarke, Amanda, Chen, Fabian, Stöhr, Wolfgang, Heslegrave, Amanda, Paton, Nicholas I., Petzold, Axel, Arenas-Pinto, Alejandro
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland MDPI AG 19.12.2023 MDPI
Predmet:	Adult Ankle biomarkers blood glucose Blood levels Blood pressure CD4 antigen CD4 lymphocyte count Complications and side effects Diabetes Diagnosis Drug resistance Drug therapy Fasting Female Glucose HIV HIV infection HIV infections HIV Infections - complications HIV Infections - drug therapy Human immunodeficiency virus Humans Male males Metabolic Syndrome monotherapy Neurotoxicity odds ratio Patient outcomes people Peripheral nerve diseases peripheral nervous system diseases Peripheral Nervous System Diseases - complications Peripheral neuropathy Plasma levels Population protease inhibitor Protease Inhibitors - therapeutic use Proteinase inhibitors Regression analysis risk Risk Factors standard deviation Statistical analysis therapeutics Toxicity Triglycerides United Kingdom metabolic syndrome protease inhibitor HIV peripheral neuropathy monotherapy
ISSN:	1999-4915, 1999-4915
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!